//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Fighting pharma power since 2010 @publiccitizen.bsky.social. We work around the world to make sure people have access to lifesaving medicines. RTs =/= Endorsements.
Access to Meds | Public Citizen









Loading...
Transparency and obligations that support broad access to medical tools are non-negotiable in pandemic prevention, preparedness and response. Public Citizen, @Saludporderecho.bsky.social, and @hai-org.bsky.social are calling on the EU and others to step up: saludporderecho.org/mpox-y-acces...
2mo
Public Citizen’s Peter Maybarduk told ICIJ that pharma created a system of rules to protect drugmakers and ensure wealthy governments protect them “There is a whole architecture underpinning Keytruda and every patented drug where the US government and Europe go to bat for the industry and its rules”
Thanks @fastlerner.bsky.social and @annamaria.bsky.social for speaking with us about the Trump admin’s unprecedented demands for data access in exchange for global health funding. Our new analysis of the few publicly-available health agreements: www.citizen.org/wp-content/u...
2mo
1d
Holding HIV treatment hostage to extract mineral deals is indefensible. More than a million Zambians rely on this aid. This administration always finds a new low. www.nytimes.com/2026/03/16/h...
Pfizer’s CEO said Pharma may “stop supplying” countries that don’t pay more in response to Trump’s threats & pressure campaign. This would be a classic “working failure,” grounds for compulsory license in every patent law. Drugmakers that threaten supply lose monopoly privileges. We wrote Bourla:
Access to Meds | Public Citizen
2mo
#CancerCalculus: An ICIJ-led collaboration with 47 media partners in 37 countries reveals how Merck & Co. keeps the price of its lifesaving cancer drug Keytruda sky-high, locking out patients and squeezing health care systems worldwide. www.icij.org/investigatio...
Americans aren’t going bankrupt from their cancer treatment because Europeans are getting the same treatment for less. They are going broke so pharma CEOs can get their multi-million dollar paydays, and they are going broke so pharma can enrich shareholders w/ billions in dividends & stock buybacks.
Letter here: www.citizen.org/article/publ...
3mo
Here the summary of this ask and transparency action we did we @publiccitizen.bsky.social and @hai-org.bsky.social saludporderecho.org/en/mpox-and-...
In a statement on behalf of HAI, @publiccitizen.bsky.social & @saludporderecho.bsky.social to 6th IGWG meeting on the #PandemicAgreement, we warned that a vague text with no binding obligations, workable schemes or enforceable commitments cannot be considered a success: haiweb.org/media-resour...
Access to Meds | Public Citizen
2mo
3mo
Access to Meds | Public Citizen
3mo
www.citizen.org
2mo
La mpox ha vuelto a situar en primer plano los desafíos pendientes en la respuesta global a las crisis sanitarias. Es una enfermedad infecciosa que en pocos años ha provocado
saludporderecho.org
Mpox y acceso global: las mismas barreras de siempre
2mo